PENNY GOLDEN STOCKS/10 BAGGERS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : PENNY GOLDEN STOCKS/10 BAGGERS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Tadsamillionaire	10/31/2007 12:57:26 PM
	of 241

FMTI up on NEWS! Forbes Medi-Tech Enters Final Steps in Compound Selection for Asthma and Type 2 Diabetes Tuesday October 30, 8:00 am ET Forbes Medi-Tech Inc. (Toronto:FMI.TO - News)(NasdaqCM:FMTI - News) today announced that it has entered the final stages of compound selection for two of the most rapidly growing therapeutic indications, asthma and type 2 diabetes. Compounds in development are chosen on the basis of selectivity (the ability to home in on one receptor), potency and pharmacokinetics (drug distribution in the body over time). Compounds targeting these indications and exhibiting the desired characteristics are present in the FM-TP2000 and 3000 Series. Potential first in class; - A level of efficacy comparable to that of GLP-1 analogs (e.g. Byetta®(i)) or DPP4 inhibitors (e.g. Januvia®(ii)) which act through a hormonal pathway, versus the complementary neural pathway driven by VPAC2 agonists; - An excellent safety profile and; - A complementary effect to GLP-1's when used in combination (60-80% of diabetics are on multiple medications according to IMF2004). biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next